Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12521
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLim, Yen Ying-
dc.contributor.authorPietrzak, Robert H-
dc.contributor.authorBourgeat, Pierrick-
dc.contributor.authorAmes, David-
dc.contributor.authorEllis, Kathryn A-
dc.contributor.authorRembach, Alan-
dc.contributor.authorHarrington, Karra-
dc.contributor.authorSalvado, Olivier-
dc.contributor.authorMartins, Ralph N-
dc.contributor.authorSnyder, Peter J-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorMaruff, Paul-
dc.date.accessioned2015-05-16T02:13:46Z
dc.date.available2015-05-16T02:13:46Z
dc.date.issued2014-12-02-
dc.identifier.citationArchives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists 2014; 30(1): 49-58en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12521en
dc.description.abstractWe investigated the extent to which decline in memory and working memory in beta-amyloid (Aβ) positive non-demented individuals was related to hippocampal atrophy and Aβ accumulation over 36 months. Cognitively normal older adults (CN) (n = 178) and adults with mild cognitive impairment (MCI) (n = 49) underwent positron emission tomography neuroimaging, magnetic resonance imaging, and cognitive assessments at baseline, 18- and 36-months. Relative to Aβ- CNs, Aβ+ CNs and Aβ+ MCIs showed greater rates of cognitive decline, Aβ accumulation, and hippocampal atrophy. Analysis of interrelationships between these Alzheimer's disease markers in Aβ+ CNs and MCIs indicated that rate of Aβ accumulation was associated with rate of hippocampal atrophy (β = -0.05, p = .037), which was in turn associated independently with rate of decline in memory (β = -0.03, p = .032). This suggests that Aβ accumulation precedes any neurodegeneration or clinical symptoms, and that the relationship between Aβ and cognitive decline is mediated by hippocampal atrophy.en
dc.language.isoenen
dc.subject.otherEpisodic memoryen
dc.subject.otherHippocampal volumeen
dc.subject.otherMCIen
dc.subject.otherNeuropsychological assessmenten
dc.subject.otherPreclinical ADen
dc.subject.otherβ-amyloiden
dc.titleRelationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.en
dc.typeJournal Articleen
dc.identifier.journaltitleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologistsen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Kew, Victoria, Australiaen
dc.identifier.affiliationDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USAen
dc.identifier.affiliationAcademic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Kew, Victoria, Australiaen
dc.identifier.affiliationCommonwealth Scientific Industrial Research Organization Preventative Health National Research Flagship, Australian e-Health Research Centre-BioMedIA, Brisbane, QLD, Australiaen
dc.identifier.affiliationNational Ageing Research Institute, Parkville, Victoria, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia Cogstate Ltd., Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Neurology, Warren Alpert School of Medicine, Brown University, Providence, RI, USAen
dc.identifier.affiliationDepartment of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationCentre of Excellence for Alzheimer's Disease Research and Care, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Perth, WA, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia Department of Neurology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA yen_ying_lim@brown.edu.en
dc.identifier.doi10.1093/arclin/acu068en
dc.description.pages49-58en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25467942en
dc.type.contentTexten
dc.type.austinJournal Articleen
local.name.researcherMasters, Colin L
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

44
checked on Oct 31, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.